Key result
Voltage-guided EMB confirms cardiac sarcoidosis in ~67% of suspected cases.
Why the study?
Cardiac sarcoidosis diagnosis is challenging due to heterogeneous presentation and limited sensitivity of conventional fluoroscopy-guided endomyocardial biopsy.
Case Report (n=3)
No
Electroanatomic voltage mapping-guided endomyocardial biopsy is a feasible and safe adjunctive tool that can improve diagnostic yield for isolated cardiac sarcoidosis when used within a multimodal imaging framework.
Answers are grounded in this paper and cite their sources.
May support voltage-guided biopsy feasibility in suspected isolated cardiac sarcoidosis; leaves open need for prospective validation in multimodal frameworks.
Cardiac sarcoidosis is challenging to diagnose given its heterogeneous presentation and the limited sensitivity of conventional fluoroscopy-guided endomyocardial biopsy. As a result, diagnosis is often delayed or missed entirely. Electroanatomic mapping-guided endomyocardial biopsy has emerged as a strategy to improve diagnostic yield and is, for the first time, acknowledged in the 2025 European Society of Cardiology guidelines for myocarditis and pericarditis with a Class IIa recommendation, should biopsy be indicated. We present 3 cases illustrating the diagnostic utility and limitations of electroanatomic-guided endomyocardial biopsy within a multimodal diagnostic framework for cardiac sarcoidosis.
No takes yet. Share an insight, caveat, or question.
Wörgötter et al. (2026) conducted a case report in Isolated cardiac sarcoidosis (n=3). Electroanatomic voltage-guided endomyocardial biopsy was evaluated on Histological confirmation of cardiac sarcoidosis. Electroanatomic voltage-guided endomyocardial biopsy successfully provided histological confirmation of isolated cardiac sarcoidosis in 2 out of 3 suspected cases.
Synapse has enriched 10 related papers. Consider them for comparative context: